1. Home
  2. TWIN vs PBYI Comparison

TWIN vs PBYI Comparison

Compare TWIN & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$15.79

Market Cap

224.5M

Sector

Industrials

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$5.62

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
PBYI
Founded
1918
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.5M
263.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TWIN
PBYI
Price
$15.79
$5.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$7.00
AVG Volume (30 Days)
30.0K
531.2K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
1.03%
N/A
EPS Growth
N/A
59.87
EPS
0.02
0.74
Revenue
$347,837,000.00
$211,995,000.00
Revenue This Year
$10.79
N/A
Revenue Next Year
$8.43
N/A
P/E Ratio
$841.48
$7.16
Revenue Growth
14.24
N/A
52 Week Low
$6.16
$2.58
52 Week High
$17.08
$6.12

Technical Indicators

Market Signals
Indicator
TWIN
PBYI
Relative Strength Index (RSI) 56.99 62.87
Support Level $15.44 $4.84
Resistance Level $16.27 $5.11
Average True Range (ATR) 0.61 0.20
MACD 0.05 0.07
Stochastic Oscillator 85.85 97.08

Price Performance

Historical Comparison
TWIN
PBYI

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: